SINGAPORE (May 18): Thai Beverage’s (ThaiBev) weak 2QFY20 results ended March 31 may have led analysts to downgrade the stock.

But others have kept their respective ratings for the stock as they believe the company is able to withstand the impact from measures to curb the novel coronavirus (Covid-19) pandemic.

For instance, both DBS Group Research and Phillip Securities have maintained their “buy” ratings, albeit with lower target prices of 90 cents and 80 cents, respectively.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook